In addition, high concentrations of T-tau and P-tau in CSF-due to cortical neuronal loss and cortical tangle formation, respectively- and low concentrations of Aβ1–42 due to cortical amyloid deposition, have been described as useful biomarkers for AD diagnosis [29,30]. The gene discussed is MAPT; the disease is Alzheimer disease.